TIMEPOINTa | June to August 2018 | Study period (September 2018 to September 2019) | |||||||
---|---|---|---|---|---|---|---|---|---|
Formative study | Enrolment | Allocation | Post-allocation | Postnatal and Close-out | |||||
Phase I |  | t0 (Baseline) | (ANC #1 (8–12 weeks) | ANC#2 (24–26 weeks) | t1 (ANC# 3 (32 weeks) | ANC#4 | t2 Delivery | t3 Postnatal | |
Key informant interviews and focus group discussions | X | Â | Â | Â | Â | Â | Â | Â | Â |
Enrolment: | |||||||||
Eligibility screen | Â | X | Â | Â | Â | Â | Â | Â | Â |
Informed consent | Â | X | Â | Â | Â | Â | Â | Â | Â |
Pre-assessment demographics | Â | X | Â | Â | Â | Â | Â | Â | Â |
Allocation | Â | Â | X | Â | Â | Â | Â | Â | Â |
Interventions | |||||||||
[Group A e-vouchers and mobile phones] | Â | Â | Â | X | X | X | x | X | X |
[Group B control, standard care] | Â | Â | Â | X | X | X | x | X | X |
Assessments | |||||||||
[medical history, examination, drug history, malaria/HIV screening, antenatal history, hep B screening, on ARV, preeclampsia, echography/fetal movements] | Â | Â | X | X | X | x | x | X | Â |
[outcomes, #ANC, delivery, MMR,FP] | Â | Â | X | Â | X | Â | X | Â | X |
[Exclusive breastfeeding] | Â | Â | Â | Â | Â | Â | Â | Â | X |
CHW weekly follow-up | Â | Â | X | X | X | x | x | X | X |
Resource utilization and management | x | X | X | X | x | x | x | x | X |
Economic analysis | Â | Â | Â | Â | Â | Â | Â | Â | X |
Post Intervention FGD | Â | Â | Â | Â | Â | Â | Â | Â | X |